After-hours trading sees RF Acquisition Corp (RFAI) shares soar by almost 500% following approval of merger with Nanyang Biologics.

RFAI · RF Acquisition Corp II

The AI's read

RFAI shareholders approved a business combination with Nanyang Biologics and the stock exploded roughly 500% after hours. The vote also removed blank-check provisions and cleared Nasdaq share issuance and incentive plans, so the SPAC is now a live biotech story. The market already front-ran the headline with a massive move, so most obvious upside looks priced in after the 500%+ jump. RSI sits in the mid-60s, not extreme, but the price action has digested the core news. We lean neutral. Fresh, idiosyncratic catalyst but near-term upside is compressed until final redemption totals, regulatory steps, and the deal close give new info.